Conjunctival malt lymphoma successfully treated with single agent rituximab therapy.
Salepci
Taflan
T
Seker
Mesut
M
Kurnaz
Ekrem
E
Guler
Derya Oztas
DO
Bilici
Ahmet
A
Dane
Faysal
F
Aliustaoglu
Mehmet
M
Atesoglu
Elif Birtas
EB
Gumus
Mahmut
M
Yaylaci
Mustafa
M
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D003230:Conjunctival Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy*; D012074:Remission Induction; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab